Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share - Put (RGLS)

Quarterly Holders Quick Answers

Related Filing Research

• Latest 13F filings for newly reported positions.
• Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
• Latest 10-Q/10-K reports for financial context tied to this issuer.
• Recent insider transactions for executive and insider activity.
• SEC investors directory and top value investors for manager drilldown.
• Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

• Previous quarter: Q2 2025

Recent filing periods for CUSIP 75915K309: